Leslie Perez - Concepedia

Author

Leslie Perez

Also Known As

Leslie Perez

Publications

450

Citations

H-Index

Concepts

All Affiliations

Leslie Perez is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, pharmacology, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	86
2	Pharmacology	2	2	86
3	Immunology	1	1	32
4	Pathology	1	1	54
5	Cancer Genetics	1	1	54

Leslie Perez

Publications

442

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Journal of Clinical Oncology	2021	183
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas Alison J. Moskowitz, Paola Ghione, Eric D. Jacobsen, Blood	2021	159
A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR -Mutant Lung Adenocarcinomas with Acquired Resistance to Erlotinib Helena A. Yu, Leslie Perez, Qing Chang, Journal of Thoracic Oncology Phase 1/2OncologyAcquired ResistanceMedicinePathology	2016	54
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial Steven M. Horwitz, Ajit J. Nirmal, Jahan Rahman, Nature Medicine Lymphoid NeoplasiaMedicineImmunologyPharmacologyPhase 1B/2a	2024	32
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Pallawi Torka, Tatyana Feldman, Kerry J. Savage, Journal of Clinical Oncology	2024	14

Page 1